Latest News
Overcoming Healthcare’s catch-22: How to ditch these five risky habits
https://blogs.cisco.com/healthcare/overcoming-healthcares-catch-22-how-to-ditch-these-five-risky-habits
Author
Author: Rich Benvin
Latest News
HIMSS Analytics Developing a New Standard for Measuring Hospital Infrastructure Adoption
https://blogs.cisco.com/healthcare/himss-analytics-developing-a-new-standard-for-measuring-hospital-infrastructure-adoption
Latest News
Ask a cybersecurity expert: What are the top 4 tips for securing health data?
https://blogs.cisco.com/healthcare/ask-a-cybersecurity-expert-what-are-the-4-top-tips
Latest News
The Wait is Almost Over: HIMSS Analytics INFRAM Provides a Roadmap to Infrastructure Maturity
https://blogs.cisco.com/healthcare/the-wait-is-almost-over-himss-analytics-infram-provides-a-roadmap-to-infrastructure-maturity
Latest News
It’s Here: HIMSS Analytics INFRAM Now Available for Healthcare Organizations
https://blogs.cisco.com/healthcare/its-here-himss-analytics-infram-now-available-for-healthcare-organizations
Cancer
Bladder Cancer Risk Higher With Radiation Therapy for Prostate Cancer
https://www.cancertherapyadvisor.com/bladder-cancer-higher-risk-for-prostate-surgery-treatment-risk/article/806723/
Cancer
Native Puerto Ricans Are at Increased Risk for Certain Cancers
https://www.cancertherapyadvisor.com/native-puerto-ricans-higher-cancer-risk/article/806546/
Cancer
Radiotherapy Did Not Improve Survival in All Patients With Metastatic Prostate Cancer
https://www.cancertherapyadvisor.com/radiotherapy-did-not-improve-survival-in-all-patients-with-metastatic-prostate-cancer/article/810701/
Cancer
Atezolizumab and Nab-Paclitaxel Prolonged PFS in Metastatic Triple-Negative Breast Cancer
https://www.cancertherapyadvisor.com/breast-cancer-atezolizumab-nab-paclitaxel-prolongs-survival-treatment/article/808965/
Cancer
Reducing Trastuzumab Duration Lowers Costs by Nearly £10,000 in HER2-positive Breast Cancer
https://www.cancertherapyadvisor.com/trastuzumab-duration-lowers-cost-breast-cancer-uk-study-effective/article/809064/
Cancer
20-Year Data Link High-Dose Chemotherapy and Hematopoietic Stem Cell Transplant to Survival Benefit in High-Risk Early Breast Cancer
https://www.cancertherapyadvisor.com/breast-cancer-stem-cell-transplant-chemo-benefits-hsct-survival/article/809066/
Cancer
Talazoparib Improves PROs in BRCA-Positive Triple-Negative Breast Cancer
https://www.cancertherapyadvisor.com/breast-cancer-talazoparib-pro-improves-treatment-risk/article/809070/
Cancer
Where Have All the T Cells Gone?
https://www.cancertherapyadvisor.com/t-cell-glioblastoma-tumors-new-mechanism/article/788259/
Cancer
Novel Regimen for High-Risk CLL Patients Seeking Transplantation
https://www.cancertherapyadvisor.com/chronic-leukemia-cll-novel-regimen-patients-seeking-transplant/article/810245/
Cancer
Bortezomib-Based Frontline Therapy Boosts Survival in Mantle Cell Lymphoma
https://www.cancertherapyadvisor.com/mantle-cell-lymphoma-bortezomib-frontline-therapy-boosts-survival/article/810090/
Cancer
Commission Calls for Integration of Oncology and Palliative Care
https://www.cancertherapyadvisor.com/oncology-palliative-care-commission-calls-integration-treatment/article/810379/
Cancer
Efforts Made in the 1960s to Curb Smoking Will Have Effects Well Into Future
https://www.cancertherapyadvisor.com/efforts-made-1960s-curb-smoking-will-have-effects-well-into-future/article/810697/
Cancer
Radiotherapy Did Not Improve Survival in All Patients With Metastatic Prostate Cancer
https://www.cancertherapyadvisor.com/radiotherapy-did-not-improve-survival-in-all-patients-with-metastatic-prostate-cancer/article/810701/
Cancer
Novel Regimen for High-Risk CLL Patients Seeking Transplantation
https://www.cancertherapyadvisor.com/chronic-leukemia-cll-novel-regimen-patients-seeking-transplant/article/810245/
Cancer
Bortezomib-Based Frontline Therapy Boosts Survival in Mantle Cell Lymphoma
https://www.cancertherapyadvisor.com/mantle-cell-lymphoma-bortezomib-frontline-therapy-boosts-survival/article/810090/
